SG11202103605WA - Compositions comprising bacterial strains - Google Patents
Compositions comprising bacterial strainsInfo
- Publication number
- SG11202103605WA SG11202103605WA SG11202103605WA SG11202103605WA SG11202103605WA SG 11202103605W A SG11202103605W A SG 11202103605WA SG 11202103605W A SG11202103605W A SG 11202103605WA SG 11202103605W A SG11202103605W A SG 11202103605WA SG 11202103605W A SG11202103605W A SG 11202103605WA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18199455 | 2018-10-09 | ||
| PCT/EP2019/077332 WO2020074569A1 (en) | 2018-10-09 | 2019-10-09 | Compositions comprising bacterial strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103605WA true SG11202103605WA (en) | 2021-05-28 |
Family
ID=63862002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103605WA SG11202103605WA (en) | 2018-10-09 | 2019-10-09 | Compositions comprising bacterial strains |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20210299190A1 (en) |
| EP (1) | EP3863653A1 (en) |
| JP (1) | JP2022504185A (en) |
| KR (1) | KR20210076012A (en) |
| CN (1) | CN112823013A (en) |
| AU (1) | AU2019358439A1 (en) |
| BR (1) | BR112021006660A2 (en) |
| CA (1) | CA3115590A1 (en) |
| EA (1) | EA202190876A1 (en) |
| IL (1) | IL281951A (en) |
| MA (1) | MA53860A (en) |
| MX (1) | MX2021004150A (en) |
| SG (1) | SG11202103605WA (en) |
| TW (1) | TW202027767A (en) |
| WO (1) | WO2020074569A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202103605WA (en) * | 2018-10-09 | 2021-05-28 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| KR102470808B1 (en) * | 2020-11-02 | 2022-11-28 | 주식회사 바이오미 | Composition for the preventation or treatment of inflammatory bowel disease |
| WO2023216181A1 (en) | 2022-05-12 | 2023-11-16 | N.V. Nutricia | Improving micriobiota of infants born by caesarean section |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| US20100168410A1 (en) | 2006-10-27 | 2010-07-01 | Pfizer Products Inc. | Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| EP2951285A4 (en) * | 2013-02-04 | 2016-10-26 | Seres Therapeutics Inc | Compositions and methods for inhibition of pathogenic bacterial growth |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| MA41020A (en) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND THEIR METHODS OF USE FOR MODULATION OF THE MICROBIOME |
| JP6271093B1 (en) * | 2014-12-23 | 2018-01-31 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | Immunoregulation |
| MA41010B1 (en) * | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| SG11202103605WA (en) * | 2018-10-09 | 2021-05-28 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
-
2019
- 2019-10-09 SG SG11202103605WA patent/SG11202103605WA/en unknown
- 2019-10-09 MX MX2021004150A patent/MX2021004150A/en unknown
- 2019-10-09 CN CN201980066326.5A patent/CN112823013A/en active Pending
- 2019-10-09 EP EP19794894.6A patent/EP3863653A1/en active Pending
- 2019-10-09 JP JP2021518476A patent/JP2022504185A/en active Pending
- 2019-10-09 EA EA202190876A patent/EA202190876A1/en unknown
- 2019-10-09 MA MA053860A patent/MA53860A/en unknown
- 2019-10-09 TW TW108136758A patent/TW202027767A/en unknown
- 2019-10-09 WO PCT/EP2019/077332 patent/WO2020074569A1/en active Search and Examination
- 2019-10-09 AU AU2019358439A patent/AU2019358439A1/en not_active Abandoned
- 2019-10-09 KR KR1020217011650A patent/KR20210076012A/en unknown
- 2019-10-09 CA CA3115590A patent/CA3115590A1/en active Pending
- 2019-10-09 BR BR112021006660-8A patent/BR112021006660A2/en not_active Application Discontinuation
-
2021
- 2021-03-31 IL IL281951A patent/IL281951A/en unknown
- 2021-04-09 US US17/226,148 patent/US20210299190A1/en not_active Abandoned
- 2021-12-01 US US17/539,674 patent/US20220088088A1/en not_active Abandoned
-
2023
- 2023-04-05 US US18/295,874 patent/US20230302062A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020074569A8 (en) | 2020-10-01 |
| IL281951A (en) | 2021-05-31 |
| JP2022504185A (en) | 2022-01-13 |
| US20210299190A1 (en) | 2021-09-30 |
| AU2019358439A1 (en) | 2021-06-03 |
| US20220088088A1 (en) | 2022-03-24 |
| CN112823013A (en) | 2021-05-18 |
| EP3863653A1 (en) | 2021-08-18 |
| WO2020074569A1 (en) | 2020-04-16 |
| MA53860A (en) | 2021-09-15 |
| CA3115590A1 (en) | 2020-04-16 |
| KR20210076012A (en) | 2021-06-23 |
| TW202027767A (en) | 2020-08-01 |
| US20230302062A1 (en) | 2023-09-28 |
| EA202190876A1 (en) | 2021-07-02 |
| BR112021006660A2 (en) | 2021-07-20 |
| MX2021004150A (en) | 2021-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283751A (en) | Compositions comprising bacterial strains | |
| SG11202011028SA (en) | Compositions comprising bacterial strains | |
| IL277422A (en) | Compositions comprising bacterial strains | |
| IL281951A (en) | Compositions comprising bacterial strains | |
| IL280895A (en) | Compositions comprising bacterial strains | |
| IL279963A (en) | Compositions comprising bacterial strains | |
| IL279339A (en) | Compositions comprising bacterial strains | |
| IL282439A (en) | Compositions comprising bacterial strains | |
| IL279724B (en) | Compositions comprising bacterial strains | |
| PT3723777T (en) | Compositions comprising bacterial strains | |
| PT3743086T (en) | Compositions comprising bacterial strains | |
| GB201820744D0 (en) | Compositions comprising bacterial strains | |
| GB201820745D0 (en) | Compositions comprising bacterial strains | |
| GB201820256D0 (en) | Compositions comprising bacterial strains | |
| GB201820230D0 (en) | Compositions comprising bacterial strains | |
| GB201820261D0 (en) | Compositions comprising bacterial strains | |
| GB201820264D0 (en) | Compositions comprising bacterial strains | |
| GB201817648D0 (en) | Compositions comprising bacterial strains | |
| GB201817642D0 (en) | Compositions comprising bacterial strains | |
| GB201817641D0 (en) | Compositions comprising bacterial strains | |
| GB201814836D0 (en) | Compositions comprising bacterial strains | |
| GB201813460D0 (en) | Compositions comprising bacterial strains | |
| GB201813423D0 (en) | Compositions comprising bacterial strains | |
| GB201812378D0 (en) | Compositions comprising bacterial strains | |
| GB201811900D0 (en) | Compositions comprising bacterial strains |